Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT-Resistant Variants of HIV-1.-Reference-Cited by-同舟云学术

Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT-Resistant Variants of HIV-1.

Published:1990-12 Issue:1 AIDS Volume:616 Page:346-355
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann NY Acad Sci

Author:

WAINBERG MARK A.,TREMBLAY MICHEL,ROOKE RONALD,BLAIN NORMAND,SOUDEYNS HUGO,PARNIAK MICHAEL A.,YAO X-J,LI X-G,FANNING MARY,MONTANER JULIO S. G.,O'SHAUGHNESSY MICHAEL,TSOUKAS CHRISTOS,FALUTZ JULIAN,DIONNE GERVAIS,BELLEAU BERNARD,RUEDY JOHN

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1990.tb17855.x/fullpdf

Reference14 articles.

1. HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

2. Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy

3. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

4. Nature, time course and dose dependence of zidovudine-related side effects

5. The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tribute to Mark Wainberg;Retrovirology;2017-06-28

2. Evaluation of drug resistance in HIV infection;Advances in Virus Research;2002

3. Inhibitors of HIV- I reverse transcriptase;HIV-1: Molecular Biology and Pathogenesis;2000

4. HIV resistance to zidovudine: the role of pyrophosphorolysis;Drug Resistance Updates;1999-04

5. The Thiocarboxanilide Nonnucleoside Inhibitor UC781 Restores Antiviral Activity of 3′-Azido-3′-Deoxythymidine (AZT) against AZT-Resistant Human Immunodeficiency Virus Type 1;Antimicrobial Agents and Chemotherapy;1999-02